Showing 11,941 - 11,960 results of 29,412 for search '(( 50 ((teer decrease) OR (a decrease)) ) OR ( 5 ((step decrease) OR (nn decrease)) ))', query time: 0.89s Refine Results
  1. 11941

    DataSheet_1_Biologically Active α-Amino Amide Analogs and γδ T Cells—A Unique Anticancer Approach for Leukemia.pdf by Ahmed Al Otaibi (11111187)

    Published 2021
    “…Cytotoxicities and IC<sub>50</sub> values of α-AAA-A and α-AAA-B against leukemia cancer cell lines (HL-60 and K562) were analyzed though MTT assay. …”
  2. 11942
  3. 11943

    DataSheet1_Adverse event profiles of adjuvant treatment with opicapone in Parkinson’s disease: A systematic review and meta-analysis.PDF by Luwen Xie (14167338)

    Published 2022
    “…Any TEAEs, SAEs and treatment discontinuation all occurred at rates of 62.9%, 4.8% and 9.3%, respectively. TEAEs with opicapone 50 mg that were reported by more than 5% of patients in long-term studies included dyskinesia (16.1%), dry mouth (12.1%), medication effect decreased (12.1%), PD exacerbated (7.8%), blood creatine phosphokinase level raised (7.4%), nausea (6.1%) and insomnia (5.1%). …”
  4. 11944

    Data_Sheet_1_Nationwide Initiation of Cardiovascular Risk Treatments During the COVID-19 Pandemic in France: Women on a Slippery Slope?.DOCX by Amélie Gabet (12451977)

    Published 2022
    “…In addition, the 2020 number of people visiting a family physician or cardiologist decreased by 8.4 and 7.4%. …”
  5. 11945
  6. 11946
  7. 11947
  8. 11948

    Technical Complications during Veno-Venous Extracorporeal Membrane Oxygenation and Their Relevance Predicting a System-Exchange – Retrospective Analysis of 265 Cases by Matthias Lubnow (668123)

    Published 2014
    “…<div><p>Objectives</p><p>Technical complications are a known hazard in veno-venous extracorporeal membrane oxygenation (vvECMO). …”
  9. 11949
  10. 11950
  11. 11951
  12. 11952
  13. 11953
  14. 11954
  15. 11955
  16. 11956
  17. 11957
  18. 11958
  19. 11959
  20. 11960